Next-Generation Electrical Stimulation Therapy Systems

Publication ID: 24-11857785_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Electrical Stimulation Therapy Systems,” Published Technical Disclosure No. 24-11857785_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857785_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,785.

Summary of the Inventive Concept

The present inventive concept envisions a next-generation electrical stimulation therapy system that leverages advanced technologies, such as adaptive energy harvesting, artificial intelligence, and blockchain, to provide personalized, real-time, and adaptive treatment for various medical conditions.

Background and Problem Solved

The original patent disclosed systems, methods, and devices for electrical stimulation therapy, primarily focusing on transcutaneous devices for enhancing bone healing in spinal fusion patients. However, these systems have limitations, such as battery replacement and recharging issues, lack of personalization, and limited data analytics capabilities. The new inventive concept addresses these limitations by introducing novel features that enhance treatment efficacy, patient comfort, and data security.

Detailed Description of the Inventive Concept

The next-generation electrical stimulation therapy system comprises a wearable, implantable, or injectable device with a biocompatible, adaptive, and self-sustaining energy harvesting system that eliminates the need for battery replacement or recharging. The system utilizes artificial intelligence, machine learning, and data analytics to optimize stimulation parameters based on a patient's unique physiological response, medical history, and lifestyle factors. Additionally, the system includes a neural interface with a high-resolution, implantable electrode array for precise, targeted, and adaptive stimulation of specific neural pathways. A decentralized, blockchain-based platform ensures secure, transparent, and patient-centric data management and treatment planning.

Novelty and Inventive Step

The new inventive concept introduces several novel features that distinguish it from the original patent, including adaptive energy harvesting, artificial intelligence-driven optimization, and blockchain-based data management. These advancements provide a significant inventive step, as they enable more efficient, personalized, and secure electrical stimulation therapy.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type of energy harvesting (e.g., solar, kinetic, or biochemical), using different machine learning algorithms, or incorporating additional sensors or interfaces (e.g., EEG or EMG). These variations could be tailored to specific medical conditions, patient populations, or treatment settings.

Potential Commercial Applications and Market

The next-generation electrical stimulation therapy system has significant commercial potential in various markets, including pain management, physical therapy, and neurology. The system's advanced features and personalized approach could attract patients and healthcare providers seeking more effective and efficient treatment options. The decentralized, blockchain-based platform could also enable new business models and revenue streams for data analytics, remote monitoring, and personalized treatment planning.

Field of Art

Biomedical engineering, specifically electrical stimulation therapy systems for medical treatment, with expertise in device design, signal generation, physiological monitoring, and therapeutic intervention technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degrees, knowledge of electrical stimulation techniques, sensor technologies, data analytics, and experience in developing adaptive medical devices with expertise in signal processing and patient monitoring systems

Obviousness Rationale

A PHOSITA would recognize that the PTD's proposed variations represent predictable technological extensions of the source patent's electrical stimulation framework, utilizing well-established engineering techniques to enhance existing therapeutic device capabilities through incremental improvements in energy management, data processing, and personalized treatment approaches.

Obvious Combinations & Variations

Source Patent Element
Energy source and signal generator for electrical stimulation therapy
PTD Variation
Biocompatible adaptive energy harvesting system using kinetic, thermal, or biochemical energy sources
Obviousness Reasoning
Known energy harvesting techniques applied to medical devices represent a predictable solution for eliminating battery limitations, which would be an obvious design improvement to a PHOSITA seeking more sustainable therapeutic technologies
Source Patent Element
Physiological parameter monitoring capabilities
PTD Variation
Artificial intelligence and machine learning for optimizing stimulation parameters based on patient-specific data
Obviousness Reasoning
Integrating advanced data analytics with existing sensor technologies is a standard engineering approach for enhancing medical device performance, representing a logical and predictable technological progression
Source Patent Element
Transcutaneous electrical stimulation device for therapeutic interventions
PTD Variation
High-resolution implantable neural interface with precise electrode array for targeted stimulation
Obviousness Reasoning
Advancing electrode technology and precision targeting are well-established engineering goals in medical device development, representing an obvious refinement of existing stimulation methodologies
Source Patent Element
Signal generation and patient monitoring system
PTD Variation
Blockchain-based platform for secure data management and treatment planning
Obviousness Reasoning
Implementing secure, decentralized data management represents a standard technological response to increasing privacy and data security requirements in medical technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857785 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed electrical stimulation therapy system innovations obvious and lacking inventive merit, as the combinations represent predictable technological extensions employing standard engineering techniques to enhance existing medical device capabilities.

Original Patent Information

Patent NumberUS 11,857,785
TitleSystems, methods and devices for electrical stimulation therapy
Assignee(s)Theragen, Inc.